Skip to main content

Viatris makes progress on Ozempic patent challenge

Board agrees to review patent covering certain strengths of blockbuster diabetes drug
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.